Abstracts

443 – Cross-Sectional Cognitive Profiles Better Reflect Everyday Functioning Trajectories Than HAND

Background The HIV-associated neurocognitive disorder (HAND) framework relies on fixed thresholds, domain-level averaging, and subjective report of everyday functioning, which may obscure meaningful variation and subtle decline. In contrast, Latent Profile Analysis (LPA) and Growth Mixture Modeling (GMM) offer empirical alternatives to characterize cognitive profiles (CP) and functional trajectories (FT). Together, these methods can illuminate…

751 – Cognitive and Neuropsychiatric Impairments Associated With COVID-19 in Patients Evaluated in Brazil

Background Neurological and neuropsychiatric impairments after covid-19 have been described since the beginning of the pandemic, particularly cognitive impairment, referred to as brain fog, and deficits in attention, executive function, language, processing speed, and memory are the most common symptoms. Our objective is to evaluate cognitive and neuropsychiatric impairments in patients who presented neurological manifestations associated…

766 – Pneumococcal Disease in People With HIV: Epidemiologic Trends and Vaccination Perspectives

Background Pneumococcal disease remains a frequent bacterial infection in people with HIV (PWH). Considering available and upcoming pneumococcal vaccines, accurate knowledge of epidemiological trends and serotype distribution of pneumococcal disease in PWH is essential to guide prevention strategies. Methods We performed a retrospective cohort study of all culture-confirmed episodes of pneumococcal disease in PWH aged…

773 – Efficiency of Portable Chest X-Ray Compared to Symptom-Based TB Screening in Southwest Nigeria

Background The issue of “Missing TB Cases” (cases that go undiagnosed, untreated, or unreported) is a major public health challenge in Nigeria, which ranks as the country with the highest TB burden in Africa and one of the top high-burden countries globally. Institute of Human Virology of Nigeria (IHVN), therefore, deployed an innovative, mobile Portable Digital…

428 – Safety and Viral Kinetics of Analytical Treatment Interruption in PWH in a Large Phase II Global RCT

Background Viral suppression without continuous antiretroviral therapy (ART) is an unmet need among people with HIV (PWH), and analytical treatment interruption (ATI) is used for evaluating potential therapies for long-term virologic control without lifelong ART. This phase 2 trial evaluated the safety and efficacy of budigalimab ± trosunilimab to maintain suppression in PWH undergoing ATI. Here, we describe…

825 – Long-Acting Antiretroviral Formulations Restore the Fetal Neurometabolome

Background Advances in antiretroviral drugs (ARVs) have prevented gestational human immunodeficiency virus type 1 (HIV-1) transmission from mother to fetus. This is reflected in the rising numbers of HIV-1-exposed uninfected (HEU) children. Worldwide, the number of HEU children exceeds sixteen million, with more than one million children added to this group yearly. Although HEU children…

571 – From Errors to Accuracy: Nanopore Sequencing Reliably Detects HIV Drug Resistance Variants

Background Illumina next-generation sequencing (NGS) is the benchmark for HIV drug resistance (HIVDR) monitoring. Sequencing by Oxford Nanopore Technologies (ONT) offers advantages in cost, portability, and long-read capacity, but earlier error rates raised doubts about the reliability of detected variants. This is particularly critical for minority resistant variants, which are clinically relevant in treatment failure…

852 – Efficacy and Safety of B/F/TAF in Children and Infants Aged ≥1 Month, Weighing 3 to <25 kg: Week 24

Background Treatment options for children with HIV are limited. Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is a well-tolerated antiretroviral therapy (ART) with a high barrier to resistance approved in the US for children weighing ≥14 kg and in other countries for children ≥25 kg. However, data on its use in younger children are limited. We present efficacy and safety outcomes for…

341 – Parallelized Genome-Wide Detection of Intact HIV Provirus With Bimodal Phenotyping in Single Cells

Background Prolonged cART is associated with a greater proportion of provirus in closed chromatin and shifted reservoir landscape. However, current single cell reservoir approaches are unable to detect a heterochromatic provirus while maintaining the ability to simultaneously define the features of its host CD4+ T cell. To enable rational targeting of the reservoir, we hypothesized…

891 – Longitudinal Dynamics of SARS-CoV-2 Antireceptor Binding Domain Antibodies in Healthcare Workers

Background Prior SARS-CoV-2 infection and vaccination impact the magnitude and durability of anti-receptor binding domain (RBD) IgG. We aimed to characterise longitudinal anti-RBD dynamics in HCWs with and without prior infection in the SORTED (Seroprevalence, Seroconversion Rates and Transmission Dynamics of SARS-CoV-2 among Healthcare Workers) study. Methods Recruitment occurred from July 2020 to September 2021…